These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 27184586

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 5-Year clinical follow-up of the COBRA (complex coronary bifurcation lesions: Randomized comparison of a strategy using a dedicated self-expanding biolimus A9-eluting stent vs. a culotte strategy using everolimus-eluting stents) study.
    Bennett J, Adriaenssens T, McCutcheon K, Dens J, Desmet W, Sinnaeve P, Vrolix M, Dubois C.
    Catheter Cardiovasc Interv; 2018 Nov 15; 92(6):E375-E380. PubMed ID: 29536609
    [Abstract] [Full Text] [Related]

  • 5. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
    Ming Fam J, van Der Sijde JN, Karanasos A, Felix C, Diletti R, van Mieghem N, de Jaegere P, Zijlstra F, Jan van Geuns R, Regar E.
    Catheter Cardiovasc Interv; 2017 Apr 15; 89(5):798-810. PubMed ID: 27717119
    [Abstract] [Full Text] [Related]

  • 6. COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial.
    Dubois C, Bennett J, Dens J, De Cock D, Desmet W, Belmans A, Ughi GJ, Sinnaeve P, Vrolix M, D'hooge J, Adriaenssens T.
    EuroIntervention; 2016 Apr 20; 11(13):1457-67. PubMed ID: 25947278
    [Abstract] [Full Text] [Related]

  • 7. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
    Dubois C, Adriaenssens T, Ughi G, Wiyono S, Bennett J, Coosemans M, Ferdinande B, Sinnaeve P, D'hooge J, Desmet W.
    Catheter Cardiovasc Interv; 2013 Feb 20; 81(3):E155-64. PubMed ID: 22745031
    [Abstract] [Full Text] [Related]

  • 8. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y, Serruys PW, Muramatsu T, Nakatani S, van Geuns RJ, de Bruyne B, Dudek D, Christiansen E, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Garcia-Garcia HM, Veldhof S, Rapoza R, Ormiston JA.
    JACC Cardiovasc Interv; 2014 Dec 20; 7(12):1400-11. PubMed ID: 25523532
    [Abstract] [Full Text] [Related]

  • 9. Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.
    Orvin K, Carrie D, Richardt G, Desmet W, Assali A, Werner G, Ikari Y, Fujii K, Goicolea J, Dangoisse V, Manari A, Saito S, Wijns W, Kornowski R.
    Catheter Cardiovasc Interv; 2016 May 20; 87(6):1092-100. PubMed ID: 26268482
    [Abstract] [Full Text] [Related]

  • 10. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
    Naganuma T, Kawamoto H, Panoulas VF, Latib A, Tanaka A, Mitomo S, Ruparelia N, Jabbour RJ, Chieffo A, Carlino M, Montorfano M, Colombo A.
    Int J Cardiol; 2017 Nov 01; 246():26-31. PubMed ID: 28867010
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds.
    Tanaka A, Latib A, Kawamoto H, Jabbour RJ, Mangieri A, Pagnesi M, Montalto C, Regazzoli D, Ancona M, Chieffo A, Carlino M, Montorfano M, Colombo A.
    Catheter Cardiovasc Interv; 2016 Nov 15; 88(6):854-862. PubMed ID: 27184769
    [Abstract] [Full Text] [Related]

  • 12. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
    Boeder NF, Dörr O, Bauer T, Mattesini A, Elsässer A, Liebetrau C, Achenbach S, Hamm CW, Nef HM.
    Int J Cardiol; 2017 Nov 01; 246():74-79. PubMed ID: 28579164
    [Abstract] [Full Text] [Related]

  • 13. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
    Diletti R, Serruys PW, Farooq V, Sudhir K, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Onuma Y, Garcia-Garcia HM, Chevalier B.
    Am Heart J; 2012 Nov 01; 164(5):654-63. PubMed ID: 23137495
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miquel-Hebert K, Rapoza R, García-García HM.
    Circulation; 2010 Nov 30; 122(22):2301-12. PubMed ID: 21098436
    [Abstract] [Full Text] [Related]

  • 15. Baseline and 9 months IVUS analysis of the bifurcation-dedicated biolimus A9-eluting Axxess stent system: the DIVERGE IVUS substudy.
    Buysschaert I, Sanidas E, Hasegawa T, Koo BK, Honda Y, Fitzgerald PJ, Verheye S.
    Catheter Cardiovasc Interv; 2014 Dec 01; 84(7):1062-70. PubMed ID: 24478226
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcomes after percutaneous revascularization of complex coronary bifurcation lesions using a dedicated self-expanding biolimus-eluting stent system.
    Triantafyllis AS, Bennett J, Pagourelias E, McCutcheon K, Adriaenssens T, Sinnaeve PR, Desmet W, Dubois C.
    Cardiol J; 2018 Dec 01; 25(4):470-478. PubMed ID: 29240962
    [Abstract] [Full Text] [Related]

  • 17. In vitro mechanical behavior and in vivo healing response of a novel thin-strut ultrahigh molecular weight poly-l-lactic acid sirolimus-eluting bioresorbable coronary scaffold in normal swine.
    Cheng Y, Gasior P, Ramzipoor K, Lee C, McGregor JC, Conditt GB, McAndrew T, Kaluza GL, Granada JF.
    Int J Cardiol; 2019 Jul 01; 286():21-28. PubMed ID: 30967275
    [Abstract] [Full Text] [Related]

  • 18. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.
    Džavík V, Colombo A.
    JACC Cardiovasc Interv; 2014 Jan 01; 7(1):81-8. PubMed ID: 24332424
    [Abstract] [Full Text] [Related]

  • 19. Differences in Vessel Healing Between Sirolimus- and Everolimus-Eluting Stent Implantation for Bifurcation Lesions: The J-REVERSE Optical Coherence Tomography Substudy.
    Terashita D, Otake H, Shinke T, Murasato Y, Kinoshita Y, Yamawaki M, Takeda Y, Fujii K, Yamada S, Shimada Y, Yamashita T, Yumoto K, Hirata K.
    Can J Cardiol; 2016 Mar 01; 32(3):384-90. PubMed ID: 26481078
    [Abstract] [Full Text] [Related]

  • 20. Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
    Barkholt TØ, Neghabat O, Holck EN, Andreasen LN, Christiansen EH, Holm NR.
    Catheter Cardiovasc Interv; 2022 Mar 01; 99(4):1075-1083. PubMed ID: 34967094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.